Daniel Sundheim’s Exact Sciences EXAS Stock Holding History

Daniel Sundheim’s Portfolio EXAS Stock Details EXAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-275,000	Closed	-$25.4M	–	38
2019 Q4	$25.4M	Buy	+275,000	New	+$24.2M	0.37%	23

Other funds holding EXAS

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Ensign Peak Advisors Salt Lake City, Utah $60.8B AUM 42.06% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Daniel Sundheim's EXAS Position: Q1 2020 in Review

Daniel Sundheim sold out of Exact Sciences (EXAS) in Q1 2020, closing a stake of 275,000 shares — an estimated $25.4M sold.

Daniel Sundheim first reported a position in EXAS in Q4 2019 and held it in 1 quarter. The position peaked at $25.4M in Q4 2019. 476 funds tracked by Wall St. Rank hold EXAS as of Q1 2020.

Daniel Sundheim reported no remaining Exact Sciences position as of Q1 2020 after selling out during the quarter.
Daniel Sundheim sold 275,000 Exact Sciences shares in Q1 2020, an estimated $25.4M.
Daniel Sundheim first reported a position in Exact Sciences in Q4 2019 and held it in 1 quarter.
Daniel Sundheim's Exact Sciences position peaked at $25.4M in Q4 2019.
476 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2020.

Based on D1 Capital Partners's 13F filing for Q1 2020, filed 15 May 2020.